Respiratory Muscle Training in Patients With Subacute Ischemic Stroke
Effect of Respiratory Muscle Training on Diaphragm Function and Activity Performance in Subacute Ischemic Stroke Patients: A Single-blind Randomised-controlled Trial
1 other identifier
interventional
26
1 country
1
Brief Summary
Stroke, which can occur due to many different reasons and is one of the most common neurological conditions, is one of the leading causes of disability worldwide. The most common disorders that occur after stroke are motor disorders. In addition, these patients may be accompanied by respiratory problems such as changes in breathing patterns and decreased ventilation function. Respiratory problems are an important risk factor for the development of long-term mortality for both cardiovascular diseases and stroke. With all these changes, there is a serious decrease in the activity performance of the patients. While stroke rehabilitation focuses on motor function losses, problems in pulmonary functions do not receive the necessary attention. Evaluating and treating patients from every aspect in stroke rehabilitation will further increase the effectiveness of the treatments applied. Ultrasonography (USG), which has been used in the field of healthcare for more than 40 years, works with a mechanism based on the principle of sound waves traveling and reflecting at different speeds in tissues of different densities. USG is a very useful and effective imaging method used by modern medicine as a part of examination and patient care, based on its advantages such as sound waves being harmless to living beings because they are non-ionizing, the image being real-time and being viewable at the time of the procedure, being a non-invasive method, and being inexpensive. This study will be included in the literature as an original study in terms of examining both the development of the patients and the effectiveness of the treatment in many aspects, with many parameters obtained by ultrasonography in subacute stroke patients who will receive respiratory muscle training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 4, 2024
CompletedFirst Posted
Study publicly available on registry
January 18, 2024
CompletedStudy Start
First participant enrolled
April 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 17, 2024
CompletedOctober 21, 2024
October 1, 2024
5 months
January 4, 2024
October 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximal Inspiratory Pressure (MIP)
Maximal inspiratory pressure (MIP) is the most commonly used measure to evaluate inspiratory muscle strength. Measurement of MIP is a straightforward test in which individuals are asked to perform a forceful inspiration against an occluded mouthpiece. The advantages of this test are that it is noninvasive and performed quickly.
Change from pre-interventional MIP score at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
Secondary Outcomes (7)
Chest circumference measurements
Change from pre-interventional Chest circumference measurements at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
Diaphragm movements and thickness (ultrasound)
Change from pre-interventional diaphragm movements and thickness (ultrasound) at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
Hand grip strength
Change from pre-interventional hand grip strength at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
Motor Activity Log (MAL)
Change from pre-interventional MAL at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
6 Minute Walk Test (6MWT)
Change from pre-interventional 6MWT at the end of the 30 sessions intervention that will be performed 5 days in a week at a total of 6 weeks.
- +2 more secondary outcomes
Study Arms (2)
Experimental Group
ACTIVE COMPARATORInspiratory muscle training, aerobic training, breathing exercises neurophysiologic rehabilitation will be applied to the experimental group. This treatment program will be applied 5 sessions a week and totally 30 sessions (6 weeks). * Inspiratory muscle training * Aerobic training * Breathing Exercises * Neurophysiological Exercise Program
Control Group
ACTIVE COMPARATORThe control group will receive aerobic training, breathing exercises and neurophysiological rehabilitation, excluding inspiratory muscle training. This treatment program will be applied 5 sessions a week and totally 30 sessions (6 weeks).
Interventions
Primary Outcome Measurement: 1\. Maximal Inspiratory Pressure (MIP) Secondary Outcome Measurements: 1. Chest circumference measurements 2. Diaphragm movements and thickness (ultrasound) 3. Hand grip strength (with a Jamar hand dynamometer) 4. Motor Activity Log 5. 6 Minute Walk Test (6MWT) 6. Canadian Occupational Performance Measure 7. Charlson Comorbidity Index
Primary Outcome Measurement: 1\. Maximal Inspiratory Pressure (MIP) Secondary Outcome Measurements: 1. Chest circumference measurements 2. Diaphragm movements and thickness (ultrasound) 3. Hand grip strength (with a Jamar hand dynamometer) 4. Motor Activity Log 5. 6 Minute Walk Test (6MWT) 6. Canadian Occupational Performance Measure 7. Charlson Comorbidity Index
Eligibility Criteria
You may qualify if:
- Having had a stroke for the first time,
- Being 18 years or older,
- Having an ischemic type stroke,
- At least 1 month has passed since the stroke,
- Modified Rankin Score ≥ 3,
- Ability to communicate,
- Agreeing to participate in the study.
You may not qualify if:
- Hemispatial neglect,
- Having a psychiatric disease,
- Having any breathing problems before the stroke,
- Not having any orthopedic, neurological or cardiopulmonary disease that would constitute a contraindication for the protocols to be applied,
- Being diagnosed with sarcopenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri University
Istanbul, Europe, 34668, Turkey (Türkiye)
Related Publications (1)
Akcay S, Akyol DK, Erkut U, Karagozoglu Coskunsu D, Kunduracilar Z, Bajrami A, Dinc Yavas A. Effect Of Inspiratory Muscle Training on Diaphragm Function and Activity Performance in Subacute Ischemic Stroke Patients: A Single-Blind Randomized-Controlled Trial. Neurorehabil Neural Repair. 2026 Jan 27:15459683251412282. doi: 10.1177/15459683251412282. Online ahead of print.
PMID: 41589338DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Arsida Bajrami, M.D.
IAU Medical Park Florya Hospital
- STUDY CHAIR
Zuhal Kunduracılar, Prof. Dr.
Saglik Bilimleri University
- STUDY CHAIR
Dilber Karagözoğlu Coşkunsu, Ass.Prof.
Fenerbahce University
- PRINCIPAL INVESTIGATOR
Sümeyye Akçay, PT
Saglik Bilimleri University
- STUDY CHAIR
Dudu Kübra Akyol, PT
IAU Medical Park Florya Hospital
- STUDY CHAIR
Arzu Dinç Yavaş, M.D.
IAU Medical Park Florya Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Single-blind
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 4, 2024
First Posted
January 18, 2024
Study Start
April 20, 2024
Primary Completion
September 17, 2024
Study Completion
October 17, 2024
Last Updated
October 21, 2024
Record last verified: 2024-10